RESEARCH ASSISTANT ZEYNEP ÇELEBİ SÖZENER    
Name : ZEYNEP
Surname : ÇELEBİ SÖZENER
E-Mail : zsozener@ankara.edu.tr
Phone Number :
Title : RESEARCH ASSISTANT
Unit :
Department :
Personal Information

Curriculum Vitea

Zeynep Çelebi Sözener, MD

 

Office Adress: Ankara University  School of Medicine Departmet of Chest Diseases divission of Immunology and Allergy

E-mail: zeynepsozener@gmail.com

Orchıd-ID:  0000-0002-5896-262X

Birth date: 04/May/1979

 

Education

 

Grade

Faculty/Department

University

Year

University

Medical School

Gazi University

1996-2002

Residency

Pulmonary Diseases

Ankara University

2003-2008

Fellowship

Immunology and Allergic Diseases

Ankara University

2017

Assoc.Prof

Pulmonary Diseases

 

2018

 

 

Career

 

Title

Hospital

Year

Resident

Ankara University Medical School

2003-2008

Specialist, MD

Atatürk Chest Diseases and Chest Surgery Education and Research Hospital

2008-2009

Specialist, MD

Akşehir State Hospital

2009-2011

 

Specialist, MD

Ankara University MedicalSchool Immunology and Allergic Diseases Department

2011-2017

Special Student

Hacettepe University  Graduate School of Health Sciences,Ankara (Basic Immunology and Tumor Immunology  I-II)

2012-2013

Fellowship

Ankara University MedicalSchool Immunology and Allergic Diseases Department

2017-

 

 

 

Publications:

26 Peer-reviewed articles, 6 other articles, 3 book chapters

Web of Science (Clarivate) Sum of times cited: 46

h-index: 4

 

 

 

 

Awards:

 

1-Asthma Allergy Study Group Poster Award, Turkish Thorasic Society, 2018

2- Published Congress Abstract Second Award, Turkish Thorasic Society, 2015

3- Hope Promised Successful Study Award, Turkish Thorasic Society, 2014

 

Teaching Activities:

Bedside visits, Term-4, 2017-2019

Inhalation tecniques,PEF meter and nebulizators,Term-4, 2015-2019

Prescribing practice for asthma and Allergic Rhinitis, Term-4, 2015-2019

 

Memberships to Scientific Societies

 

1. European Academy of Allergy and Clinical Immunology

2. Turkish National Allergy and Clinical Immunology Society (AID)

3. Europian Respiratory Society

4. Turkısh Thorasic Society

 

 

Publications

A. Peer-reviewed articles:

 

A.1 Kendirlinan R, Gümüşburun R, Cerci P, Özbek E, Altıner S, Çelebi Sözener Z, Soyyigit S, Aydin O and Bavbek S. Rapid drug desensitization with chemotherapeutics (platins, taxanes and others): single-center retrospective study. International Archives Allergy and Immunology.2019 DOI: 10.1159/000496745

A.2 Çelebi Sözener Z Gorgulu B, Mungan D, Sin B, Mısırlıgil  Z, Aydin O and Bavbek S. Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases. World Allergy Organisation Journal. 2018;11:39 https://doi.org/10.1186/s40413-018-0217-0

A.3 Yurtsever N, Soyyigit S, Çelebi Sözener Z, Mungan D, Köse K, Mısırlıgil Z. Is adenoidectomy and/or tonsillectomy a risk factor for allergic diseases and asthma seen in adulthood. The Eurasian Journal of Medicine. 2018: 50(3); 152-155

 Doi:10.5152/eurasianjmed.2018.17182

A.4 Çelebi Sözener Z, Ciftci F, Aydin O, Mungan D. Astımda sistemik komorbiditeler: kontrol ağırlık ve fenotip ile ilişkisi. Tüberküloz ve Toraks, 2018:66(4);288-296 Doi: 10.5578/tt.67629 (Article in Turkish)

A.5 Çelebi Sözener Z, Çıftcı F, Soyyigit S, Aydın Ö, Sen E, Mungan D, Çelık GE . Smoking attitudes of the patients with allergic rhinitis: a comparison with asthma and chronic obstructive pulmonary disease. are there differences when only upper airways are ınvolved?’. Tuberculosis and Thorax  2018:66(1);43-51 Doi: 10.5578/tt.66524

A.6 Bavbek S, R Kendirlinan, Çerçı P, Altıner S, Soyyigit S, Çelebi Sözener Z, Aydın Ö, Gümüşburun R. Rapid drug desensitization with biologics: a single-center experience with four biologics. International Archives of Allergy and Immunology. 2017:171(3-4);227-233 Doi: 10.1159/000454808

A.7 Çelebi Sözener Z, Aydın Ö, Mısırlıgil Z, Mungan D, Demırel YS, Çelik GE, Sin BA, Bavbek S. Omalizumab in non- allergic asthma: a report of 13 cases. Journal of Asthma. 2017:55(7);756-763 Doi: 10.1080/02770903.2017.1362427

A.8 Çelebi Sözener Z, Kayacan O, Akdogan B, Küçük Ö. A case of sarcoidosis: multiple osseous nodule and thyroid ınvolvement. Clinical Research in Pulmonology. 2017:5(1);1042

A.9 Çelebi Sözener Z, Aydın Ö, Demırel YS, Soyyigit S, Çerçı P, Kendirlinan R, Bavbek S, Çelik GE, Mısırlıgil Z, Sin BA, Kelesoglu A, Mungan D. Does the medical diagnosis of occupational asthma coincide with the legal diagnosis? Journal of Asthma. 2017:54(9);930-937 Doi:10.1080/02770903.2016.1277541

A.10 Türedı Ö, Çelebi Sözener Z, Kendirlinan R, Bavbek S. A case of pantoprazole anaphylaxis with cross reactivity to all proton pump ınhibitors: finding a safe alternative. Current Drug Safety. 2017:12(3);198-200  Doi:10.2174/1574886312666170711122341

A.11 Çıftcı F, Akbas A, Çelebi Sözener Z, Çelık G. Chronic hypersensitivity pneumonitis treated with azathioprine. Acta Medica Mediterranea. 2016:32(4);967-972

Doi: 10.19193/0393-6384_2016_4_117

A.12 Çelebi Sözener Z, Aydın Ö, Mungan D, Mısırlıgil Z. Obesity-asthma phenotype: effect of weight gain on asthma control in adults. Allergy and Asthma Proceedings. 2016:37(4);311-317 Doi: 10.2500/aap.2016.37.3949

A.13 Çelebi Sözener Z, Mısırlıgıl MS, Çerçı P, Aydın Ö, Kendirlinan R, Sin BA, Mısırlıgil Z. Eriskin astımlı hastanın ınfluenza asısina yaklasımı farklı mı? Tüberküloz ve Toraks, 2016:64(4);269-274  Doi: 10.5578/tt.42397 (Article in Turkish)

 A.14 Aydın Ö, Çelebi Sözener Z, Soyyigit S, Kendirlinan R, Gençtürk Z, Mısırlıgil Z, Mungan D, Sin BA, Demırel YS, Çelık GE, Bavbek S. Omalizumab in the treatment of allergic bronchopulmonary aspergillosis: one center’s experience with 14 cases. Allergy and Asthma Proceedings. 2015:36(6);493-500 Doi: 10.2500/aap.2015.36.3909

A.15 Yılmaz I, Çelik GE, Aydın Ö, Kepil Özdemır S, Soyyigit S, Çelebi Sözener Z, Özgüçlü S, Atasoy Ç, Düzgün N, Mungan D, Sin BA, Demırel YS, Mısırlıgil Z. Churg-Strauss syndrome: a new endotype of severe asthma? Results of 14 Turkish patients. The Clinical Respiratory Journal. 2015:9(3);350-358 Doi:10.1111/crj.12154

A.16 Bavbek S, Aydın Ö, Çelebi Sözener Z, Yüksel S. Determinants of nocebo effect during oral drug provocation tests. Allergologia et Immunopathologia. 2015:43(4);339-345

Doi: 10.1016/j.aller.2014.04.008

A.17 Çelebi Sözener Z, Aydın Ö, Mungan D, Mısırlıgil Z. Prognosis of adult asthma: a 7-year follow-up study. Annals of Allergy, Asthma Immunology. 2015:114(5);370-373

Doi: 10.1016/j.anai.2015.02.010

A.18 Soyyigit S, Çelebi Sözener Z, Atilla E, Heper A, Kaygusuz G, Sin BA. Cold urticaria: a rare manifestation of lymphoma. Journal of Medical Cases. 2015:6(1);40-42

Doi:10.14740/jmc1803w

A.19 Çelebi Sözener Z, Özgüçlü S, Aydın Ö, Heper A, Soyyigit S, Sin BA. A rare syndrome in the differential diagnosis for angioedema. Journal of Medical Cases. 2014:5(11);579-582 Doi: 10.14740/jmc1543w

A.20 Bavbek S, Çelebi Sözener Z, Aydın Ö, Kepil Özdemır S, Gül Ü, Heper A. First case report of acute generalized exanthematous pustulosis due to ıntravenous Iopromide. Journal of Investigational Allergology Clinical Immunology. 2014:24(1);66

A.21 Bavbek S, Yılmaz I, Çelebi Sözener Z. Fixed drug eruption caused by Ornidazole and Fluconazole but not Isoconazole, Itraconazole, Ketoconazole and Metronidazole. The Journal of Dermatology. 2013:40(2);134-135 Doi: 10.1111/1346-8138.12023

A.22 Karnak D, Çelebi Sözener Z, Uçar Y, Kayı Cangır A, Demirkazık A, Kankaya D. Malign mesothelioma and gelatinous pleural fluid. Asian Pasific Journal Of Tropical Diseases. 2011:1(1);80-82  Doi: 10.1016/S2222-1808(11)60020-0

A.23 Çelebi Sözener Z, Karabıyıkoglu G, Düzgün N. Evaluation of the functional parameters in scleroderma cases with pulmonary ınvolvement. Tuberculosis and Thorax. 2010:58(3);235-41

A.24 Uçar Y, Çelebi Sözener Z, Karnak D. Endotracheal tuberculosis with obstruction. Southeast Asian J Trop Med Public Health. 2010:41(3);602-607

A.25 Çelebi Sözener Z, Kaya A, Atasoy Ç, Kılıçkap M, Numanoglu N, Savaş I. Septic pulmonary embolism: three case reports. Monaldi Archives for Chest Disease. 2008:69(2);75-77  Doi: 10. 4081 /monaldi.2008.400

A.26 Çelebi Sözener Z, Tekın M, Mungan D, Karnak Demet. A15 year-old girl with swelling of the face, legs, breast and eyes. Pediatric Annals. 2007:36(3);150-153

 

 

B. Proceedings:

 

B.1 Aydın Ö, Çelebi Sözener Z, Demirel Y, Secil D, Mungan D. Evaluation of wheat flour sensitivity and respiratory symptoms in a bread factory in Ankara, Turkey  EAACI Congress 2018:73(105);380

B.2 Çelebi Sözener Z, Ciftci F, Aydın Ö, Mungan D. Reletion of systemic comorbidities in asthma with disease control,severity ,phenotype. EACCI Congress 2018:73 (105);511

B.3 Çelık GE, Karakaya G, Öner Erkekol F, Dursun B, Gelıncık A, Aydın Ö, Çelebıoglu E, Yücel T, Yorulmaz I, Dursun E, Tezcaner Ç, Çelebı Sözener Z, Büyüköztürk S, Kalyoncu F. Long term clinical effects of aspirin desensitization in patients with NERD: Comparison of maintanence doses of 300 mg versus 600 mg aspirin. EAACI Congress 2017:72(103);221-222.

B.4 Çelebi Sözener Z, Aydın Ö, Altıner S, Kendirlinan R, Gençtürk Z, Çelık GE, Mısırlıgil Z, Mungan D. Two components of patient adherence in the treatment of asthma: regular use and correct inhaler technique.EAACI Congress 2017: 72(103); 421-422.

B.5 Sin BA, Kendirlinan R, Çerçı P, Çelebi Sözener Z, Aydın Ö, Çelık GE, Mungan D, Bavbek S, Demirel YS, Mısırlıgil Z. Re-Sting Reactions in Real Life of Patients Receiving Hymenoptera Venom Immunotherapy. EAACI Congress 2016: 71(102);438-439

B.6 Çelebi Sözener Z, Çıftcı F, Soyyigit S, Aydın Ö, Sen E, Mungan D, Çelık GE. Perceptions and attitutes of the asthma, COPD and allergic rhinitis patients towards smoking and smoking cessation. EAACI Congress 2015: 70(101); 320-320.

B.7 Yurtsever N, Soyyigit S, Çelebi Sözener Z, Mungan D, Köse K, Mısırlıgil Z. Is adenoidectomy and/or tonsillectomy a risk factor for allergic diseases and asthma seen in adult patients?. EAACI Congress 2015: 70(101);163-163

B.8 Aydın Ö, Çelebi Sözener Z, Soyyigit S, Kendirlinan R, Gençtürk Z, Mısırlıgil Z, Mungan D, Sin BA, Demırel YS, Çelık GE, Bavbek S. Omalizumab in the treatment of ABPA:one center experience with 14 cases. EAACI Congress 2015:70(101);346-347

B.9 Bavbek S, Aydın Ö, Çelebi Sözener Z, Yüksel S. Determinants of nocebo effect during oral drug provocation tests. EAACI Congress 2014:69(99); 259-259,

B.10 Çelebi Sözener Z, Aydın Ö, Mungan D, Mısırlıgil Z. Obesity-asthma phenotype effect of the obesity on the asthma course in adults. EAACI Congress 2014:69(99);519-519

B.11 Çelebi Sözener Z, Aydın Ö, Mungan D, Mısırlıgil Z. Remission in adult onset asthma and contributing factors. EAACI- WAO Congress 2013:68(97);227-227

B.12 Çelebi Sözener Z, Karabıyıkoglu G, Düzgün N. Evaluation of the functional parameters in scleroderma cases  with pulmonary ınvolvement. 19 th ERS Annual Congress, (2009)

B.13 Uçar Yıldız, Çelebı Sözener Z, Karnak D, Beder S. A case with endotracheal tuberculosıs 18 th ERS Annual Congress, (2008)

B.14 Çelebi Sözener Z, Kayacan O, Akdogan B, Küçük Ö Widespread nodular osseous lesions ın a sarcoidosis patient with thyroid ınvolvement. 17th ERS Annual Congress 2007:30(51)

B.15 Çelebi Sözener Z, Tekın M, Mungan D, Karnak D. Succesful treatment of an adolescent with Lymphedema-Distichiasis syndrome. 17th ERS Annual Congress 2007:30(51)

B.16 Çelebi Sözener Z, Kaya A, Atasoy Ç, Kılıçkap M, Savas I, Numanoglu N. Septic pulmonary embolism report of three cases.  17th ERS Annual Congress 2007:30(51)

 

 

C. Book Chapters

 

C.1 Pulmonary Diseases Handbook, Chapter name:(Surfactant replacement theraphy) (2012)., Çelebı Sözener Zeynep, Rota tıp, Editor:Tevfik Özlü, Muzaffer Metintas, Mehmet Karadag, Akın Kaya, Edition:1, Türkçe

C.2  Pulmonary Diseases Handbook, Chapter name:(Atipic pneumonia)(2012)., Çıftcı Fatma, Çelebı Sözener Zeynep, Rota Tıp, Editor:Tevfik Özlü, Muzaffer Metintas, Mehmet Karadag, Akın Kaya, Edition:1, Türkçe

C.3 Pulmonary Hypertension, Chapter name:(Pulmoner Circulation) (2007)., Karabıyıkoglu Gülseren, Önen Zeynep Pınar, Çelebı Sözener Zeynep, Antıp, Editör:Gülseren Karabıyıkoglu, Edition:1, Türkçe

 

 

D. Clinical Trials and Scientific Research projects (Sub Investigator):

D.1 Research on the Effect of a Standard Stimulation of Asthma Monitoring in the Second and Third Step Health Centers on the Disease Burden and the Establishment of the National Asthma Registry System
D.2 Determination of physical activity and nutrition perception, attitudes and behaviors in asthmatic patients and evaluation the relation between asthma control

D.3 Comparison of  specific provocation test with routine diagnostic procedures in isocyanate-induced asthma

D.4  Comparison of the Effectiveness of Pre-season and  seasonal Allergoid Immunotherapy in Patients with Pollen Sensitive Allergic Rhinitis and / or Asthma 

H.5 (ACT15102) ‘A randomized, double-blind, placebo-controlled, paralel-group, 12 week Proof- of- consept (PoC) study to assess the efficacy, safety, and tolerability of SAR 440340 and the coadministration of SAR440340 and dupilumab in patients with moderate to sever asthma who are not well controlled on inhaled corticosteroid (ICS) plus long-acting B2 adrenergic agonist (LABA) theraphy’

H.6 (QAW039A2315) ‘A 2- treatment period, randomized, placebo-controlled, multicenter paralel-group study to assess the safety of QAW039 when added to existing asthma theraphy in GINA steps 3,4 and 5 patients with uncontrolled asthma’

H.7 (QAW039A2316)  ‘A 12-week, multicentr, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to standart of care asthma theraphy in patients with uncontrolled asthma’

H.8 (MK-7264) ‘A Phase 3, randomized,double-blind, placebo controlled, 12 month study to evaluate the efficacy and safety of MK-7264 in adult Participants with Chronic Cough (PN030)’

H.9 (TRIGGER STUDY.) ‘A 52 week, randomızed, double blınd, multınatıonal, multıcentre, actıve controlled, 3-arm parallel group trıal comparıng chf 5993 200/6/12.5 μG pMDI (fıxed combınatıon of extrafıne beclometasone dıpropıonate plus formoterol fumarate plus glycopyrronıum bromıde) to chf 1535 200/6 μG pMDI (fıxed combınatıon of extrafıne beclomethasone dıpropıonate plus formoterol fumarate) alone or on top of open-label tıotropıum 2.5 μG respımat® ın patıents wıth asthma uncontrolled on hıgh doses of ınhaled cortıcosteroıds ın combınatıon wıth long-actıng ß2- agonısts’

H.10 (LIBERTY ASTHMA TRAVERSE) ‘Open-label extension study to evaluate the long term safety and tolerability of dupilumab in patients with asthma who participated in a previous dupilumab asthma clinical study’

H.11 (LIBERTY ASTHMA QUEST). ‘A Randomized, double blind, placebo-controlled, parallel group study toevaluate the eficacy and safety of dupilumab in patients with persistent asthma’

H.12 ‘A randomized, double-blind, placebo-controlled, dose -ranging study to evaluate dupilumab in patients with moderate to severe uncontrolled asthma’

H.13 (SOURCE Study) ‘A Multicentre, Randomized, Double-Blind, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dependent Asthma’

H.14 (MELTEMI study) ‘A Multicenter, Open-label,Safety Extension Study with Benralizumab (MEDI-563) for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting B2 Agonist’

H.15 (ZONDA study) ‘A Multicenter, Randomized,Double-blind,Parallel Group,Placebo-controlled, Phase 3 Efficacy and Safety Study of Benralizumab (MEDI-563) to Reduce Oral Corticosteroid Use in Patients with Uncontrolled Asthma on High Dose Inhaled Corticosteroid plus Long-Acting B2 Agonist and Chronic Oral Corticosteroid Theraphy’

H.16 (BORA Study) ‘A Multicenter, Double-blind, Randomized,Parallel Group, Phase 3 Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus Long Acting B2 Agonist’

H.17 (SIROCCO Study) (D3250C00017) ‘A multicentre, randomized, double-blind,parallel group, placebocontrolled, phase III efficacy and safety study of Benralizumab (medi-563) added to high-dose inhaled corticosteroid pluslong-acting B2 agonist in patients with uncontrolled asthma’

 

 

 

 

 

E. Citations

 

SSCI, SCI-Exp, AHCI

 

Others

Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics

4

0

Omalizumab in non-allergic Asthma: A report of 13 cases

2

0

Chronic Hypersensitivity Pneumonitis treated with Azathioprine

1

0

Eriskin Astımlı Hastanın Influenza Asısına Yaklasımı Farklı mı ?

1

1

Obesity-Asthma Phenotype: Effect of Weight Gain on Asthma Control in Adults

7

2

A case of Pantoprozol anaphylaxis with cross reactivity to all proton pump inhibitors: Finding a safe alternative

1

 

 

 

 

 

Omalizumab in The Treatment of Allergic Bronchopulmonary Aspergillosis: One Center’s Experience with 14 Cases

7

4

Churg-Strauss syndrome: a new endotype of severe asthma? Results of 14 Turkish patients

1

1

Determinants of Nocebo Effect During Oral Drug Provocation Tests

3

2

Prognosis of adult asthma: a 7-year follow-up study

4

1

First case report of acute generalized exanthematous pustulosis due to intravenous iopromide.

4

0

Fixed Drug Eruption Caused by Ornidazole and Fluconazole But Not Isoconazole, Itraconazole, Ketoconazole and Metronidazole

2

2

Evaluation of the functional parameters in scleroderma cases with pulmonary involvement.

5

0

Endotracheal Tuberculosis with Obstruction

1

1

Septic Pulmonary Embolism: Three Case Reports

4

4